Explore evidence

54.4 %The overall observed survival in the study cohort was 54.4% at 3 years.

Kenyaovarian cancerpublished 2024International journal of cancereurope_pmcdocument of 14 observations

12.4 %Among 2386 partners of HIV-positive persons who inject drugs in Kenya, 297 (12.4%) tested HCV antibody positive.

Kenyahépatite Cpublished 2022BMC infectious diseasesPubMeddocument of 4 observations

1.51 relative_riskWomen living with HIV with CD4+ T cells of less than 200 cells/μl had a 1.51-fold increased risk of having high-risk HPV.

Kenyahigh-risk HPVpublished 2023AIDS (London, England)PubMeddocument of 9 observations

3.8 RRAbuse was associated with moderate-to-severe depressive symptoms with a relative risk of 3.8.

Kenyadepressive symptomspublished 2022Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 14 observations

23 %Of 2,117 women, 23% reported breast complaints.

Kenyabreast complaintsobserved 2019 and 2020published 2026JCO global oncologyPubMeddocument of 10 observations

4 foldThere was a four fold higher rate of cerebral malaria among malaria patients at Kilifi compared with Ifakara.

Kenyapaludismepublished 1994Acta tropicaeurope_pmcdocument of 4 observations

515,000 infantsGlobally, approximately 515,000 infants with Sickle Cell Disease (SCD) are born every year.

Kenyadrépanocytosepublished 2026Annals of global healthPubMeddocument of 5 observations

Less than half of the included patients were alive 3 years after a cancer diagnosis for non-Hodgkin lymphoma in sub-Saharan Africa.

Kenyanon-Hodgkin lymphomapublished 2024The Lancet. Global healtheurope_pmcdocument of 12 observations

0.8 aORHaving more viral load results available for analysis was associated with lower odds of sustained viral suppression (adjusted odds ratio 0.80; 95% CI 0.71, 0.90).

KenyaVIH/sidapublished 2026Journal of the Pediatric Infectious Diseases SocietyPubMeddocument of 9 observations

4.73 %Hepatitis B virus (HBV) accounted for 4.73% of discarded blood units due to transfusion transmissible infections at the Kwale Satellite Blood Transfusion Centre in Kenya from 2018 to 2022.

Kenyahépatite Bobserved 2018-2022published 2024BMC public healthPubMeddocument of 7 observations

18.4 %Out of the 37 (18.4%) who returned for follow up at 2 weeks, none was either sputum smear positive or Gene-Xpert positive.

Kenyatuberculoseobserved February 2013 to February 2014published 2019African Journal of Health SciencesOpenAlexdocument of 5 observations

0 %The sensitivity of the WHO symptom screen for tuberculosis was 0% among people living with HIV receiving antiretroviral therapy in western Kenya.

Kenyatuberculosepublished 2021BMC infectious diseasesPubMeddocument of 12 observations

79 %1460 (79%) of the 1845 analyzed AHD participants were WHO stage III/IV at enrollment.

KenyaVIH/sidaobserved October 2016 to September 2019published 2023MedicinePubMeddocument of 14 observations

22.1 %22.1% of participants had both hypertension and diabetes.

Kenyadiabète (non précisé) · hypertension artériellepublished 2023BMJ openPubMeddocument of 6 observations

32 %32% of uncomplicated fevers were managed at home without the use of modern medicines in Kenya between 2001 and 2002.

Kenyafeverobserved 2001 and 2002published 2006BMC public healtheurope_pmcdocument of 10 observations

5.5 %Among 1276 pregnant Kenyan women, 70 (5.5%) tested positive for Chlamydia trachomatis.

KenyaChlamydia trachomatispublished 2024Sexually transmitted diseasesPubMeddocument of 7 observations

68.8 %The prevalence of persistent respiratory symptoms was 68.8% in rural settings among individuals in low- and middle-income countries.

Kenyapersistent respiratory symptomspublished 2022PLOS global public healtheurope_pmcdocument of 11 observationsDOI 10.1371/journal.pgph.0000805

0.2 odds_ratioGrip strength was associated with a lower risk of type 2 diabetes (adjusted odds ratio = 0.20, 95% confidence interval 0.08–0.45, P < 0.001, per standard deviation increase).

Kenyadiabète de type 2published 2021Tropical medicine & international health : TM & IHPubMeddocument of 4 observations

27.2 %The use of three or more doses of IPTpSP was 27.2% during pregnancy.

Kenyapaludismeobserved 2020published 2022Malaria journaleurope_pmcdocument of 5 observationsDOI 10.1186/s12936-022-04425-x

3.1 %Among extrauterine infections in the study cohort from Migori, Kenya, syphilis accounted for 3.1%.

Kenyasyphilispublished 2023BMC pregnancy and childbirthPubMeddocument of 18 observations

2,244 peopleTreating 2244 people who inject drugs over 2021–2025 could reduce hepatitis C virus incidence by 90% by 2030 in Kenya.

Kenyahépatite Cobserved 2021-2025published 2022AIDS (London, England)PubMeddocument of 8 observations

1.8 %The prevalence of undiagnosed diabetes among Kenyan adults aged 18–69 years was 1.8%.

Kenyadiabète (non précisé)observed 2015published 2023PloS onePubMeddocument of 6 observations

400,000,000 peopleGlucose-6-phosphate dehydrogenase (G6PD) deficiency affects over 400 million people.

KenyaGlucose-6-phosphate dehydrogenase (G6PD) deficiencypublished 1995Natureeurope_pmcdocument of 3 observations

1.25 per_100_person_yearsThe mortality rate was 1.25 per 100 person-years among patients initiated on antiretroviral therapy in central Kenya.

KenyaVIH/sidapublished 2022BMC infectious diseasesPubMeddocument of 10 observations

1.16 mortality_rate_ratioIncrease in Normalized Difference Vegetation Index was associated with increased malaria mortality (mortality rate ratio = 1.16, 95% Bayesian credible interval: 1.06–1.28).

Kenyapaludismeobserved 2008–2019published 2024BMJ global healthPubMeddocument of 8 observations